GLP2 (TIRZ) 10MG
GLP2 TIRZ is a synthetic peptide known as a dual-receptor agonist, designed to target both the glucagon-like peptide-1 (GLP-1) and
glucose-dependent insulinotropic polypeptide (GIP) receptors. In laboratory research, it is utilized to investigate the synergistic regulation of glucose homeostasis, insulin secretion, and lipid metabolism through coordinated dual-pathway signaling. For research use only.
- Dual-Agonist Metabolic Research: Investigated for its ability to activate two distinct incretin receptors simultaneously to evaluate enhanced metabolic outcomes compared to single-agonist models.
- Glycemic Control Studies: Studied for its impact on stabilizing blood glucose levels and improving insulin sensitivity in animal models of metabolic dysfunction.
| Aspect | Details |
|---|---|
| Drug Class | Dual GLP-1 / GIP receptor agonist (first-in-class dual incretin mimetic) |
| Mechanism of Action | Activates GLP-1 and GIP receptors: enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, reduces appetite via central brain signaling, improves insulin sensitivity, and promotes satiety/fullness. Also reduces food cravings and energy intake. |
| Administration | Subcutaneous injection (once weekly) |
| FDA Approvals (2026) | – Type 2 diabetes (Mounjaro): Glycemic control in adults and children ≥10 years – Chronic weight management (Zepbound): Obesity or overweight with weight-related conditions (e.g., hypertension, dyslipidemia) – Moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity – Additional benefits shown in cardiometabolic parameters (e.g., blood pressure, lipids) |
| Dosing | Start: 2.5 mg weekly for 4 weeks (initiation, not maintenance) Maintenance: Escalate to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg weekly (max 15 mg) based on response and tolerance |
| Key Clinical Trials & Weight Loss Efficacy | – SURMOUNT-1 (72 weeks, obesity no diabetes): Up to 20.9% mean body weight loss (15 mg dose); >70% lost ≥10%, many ≥20-25% – SURMOUNT-5 (head-to-head vs semaglutide): Superior weight loss (~20.2% vs ~13.7% at 72 weeks) – SURMOUNT-4 (maintenance): Continued use → ~25% total loss from baseline over ~88 weeks; withdrawal → significant regain (>25% in most within 1 year) – Overall: 18-22% average loss in obesity trials; dose-dependent |
| Additional Benefits | Superior fat loss and glucose control vs single GLP-1 agonists; improvements in waist circumference, cardiometabolic markers (BP, lipids, inflammation), sleep apnea, potential knee OA pain relief; reverses many obesity-related complications |
| Common Side Effects | Gastrointestinal (most frequent during dose escalation): nausea, vomiting, diarrhea, constipation, abdominal pain, dyspepsia, burping, fatigue, hair loss (usually mild-moderate and transient) |
| Serious/Rare Risks | Pancreatitis, gallbladder issues (cholelithiasis), hypoglycemia (low risk alone), injection-site reactions; boxed warning for thyroid C-cell tumors (observed in rodents, human relevance low but monitored) |
| Typical Use Context | Preferred for maximal weight loss in obesity/overweight; strong option for type 2 diabetes with cardiometabolic needs; often outperforms semaglutide in head-to-head trials for weight reduction |
| Notes | Results vary with adherence, diet/exercise; long-term continuation needed to maintain benefits (withdrawal often leads to regain); monitor for GI tolerance during escalation |








Jess –
Yo, this Tirzepatide from PenformTM is straight fire—same as Mounjaro but I ain’t paying pharmacy prices. Dropped 52 lbs in 4 months, appetite ghosted me. Came in 3 days, plain box, nobody knows what’s up. Cheaper and it bangs. Locked in.
Rach –
Tirzepatide vial feels deadass like Mounjaro. 38 lbs down in 3 months, cravings on mute. Way cheaper than the real deal. Showed up in 4 days, unmarked box, clean. Solid plug.
Josh D –
PenformTM Tirzepatide hittin’ just like Zepbound—49 lbs melted in 5 months. No cap, same results, fraction of the cost. Thursday order, Saturday delivery—fast and ghost mode discreet. This shit slaps.
Jueno –
Best shop, always delivers!
Thomas –
Need more like penform!